Because of the complexity of interpretation and utility of biomarker directed intervention in advanced CKD, sST2 is a much more lucrative biomarker than cTnT and NT-ProBNP for CV risk stratification particularly in kidney transplant candidates where evidence based CV assessment is lacking. Here, TNNT2 is linked to chronic kidney disease.